Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanciulli

Showing results (451-460 of 602) with videos related to

Pageof 61
Sort By:
Neurology|April 13, 2012
LGI1 microdeletion in autosomal dominant lateral temporal epilepsyM Fanciulli, L Santulli, L Errichiello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2023
Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mgFrancisco Tejerina, Rosalía Palomino, Pilar Catalan, et al.
Movement Disorders Clinical Practice|April 25, 2024
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item ScoreAlessandra Fanciulli, Iva Stankovic, Omer Avraham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2025
Real-world effectiveness and safety of BIC/FTC/TAF in comparison with other regimens in people with HIV starting therapy with AIDS-defining conditions. Results from the CORIS Cohort: The ACTUAS II StudyIgnacio Pérez-Valero, Diana Corona Mata, Angela Camacho Espejo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
Sex and age-related differences in humoral and cellular responses to the recombinant zoster vaccine in people living with HIVCristina Díez, Carlos Pita-Martínez, Marta Quero-Delgado, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2026
Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic FailurePatricio Millar Vernetti, Jose-Alberto Palma, Italo Biaggioni, et al.
Cancer Cell|August 17, 2010
Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activationTiziana Bruno, Agata Desantis, Gianluca Bossi, et al.
Science Advances|April 28, 2023
ZFP750 affects the cutaneous barrier through regulating lipid metabolismAlessio Butera, Massimiliano Agostini, Matteo Cassandri, et al.
International Journal of Molecular Sciences|December 11, 2022
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA ExplorationEriseld Krasniqi, Frauke Goeman, Claudio Pulito, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escapeMatteo Caforio, Cristina Sorino, Ignazio Caruana, et al.
Pageof 61

Showing results (451-460 of 602) with videos related to

Sort By:
Pageof 61
Neurology|April 13, 2012
LGI1 microdeletion in autosomal dominant lateral temporal epilepsyM Fanciulli, L Santulli, L Errichiello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2023
Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mgFrancisco Tejerina, Rosalía Palomino, Pilar Catalan, et al.
Movement Disorders Clinical Practice|April 25, 2024
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item ScoreAlessandra Fanciulli, Iva Stankovic, Omer Avraham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2025
Real-world effectiveness and safety of BIC/FTC/TAF in comparison with other regimens in people with HIV starting therapy with AIDS-defining conditions. Results from the CORIS Cohort: The ACTUAS II StudyIgnacio Pérez-Valero, Diana Corona Mata, Angela Camacho Espejo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
Sex and age-related differences in humoral and cellular responses to the recombinant zoster vaccine in people living with HIVCristina Díez, Carlos Pita-Martínez, Marta Quero-Delgado, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2026
Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic FailurePatricio Millar Vernetti, Jose-Alberto Palma, Italo Biaggioni, et al.
Cancer Cell|August 17, 2010
Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activationTiziana Bruno, Agata Desantis, Gianluca Bossi, et al.
Science Advances|April 28, 2023
ZFP750 affects the cutaneous barrier through regulating lipid metabolismAlessio Butera, Massimiliano Agostini, Matteo Cassandri, et al.
International Journal of Molecular Sciences|December 11, 2022
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA ExplorationEriseld Krasniqi, Frauke Goeman, Claudio Pulito, et al.
Journal for Immunotherapy of Cancer|March 19, 2021
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escapeMatteo Caforio, Cristina Sorino, Ignazio Caruana, et al.
Pageof 61